Turmeric and Turmeric-containing Tablets and Sebum Production

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03065504
Recruitment Status : Active, not recruiting
First Posted : February 28, 2017
Last Update Posted : November 7, 2017
Information provided by (Responsible Party):
University of California, Davis

November 1, 2016
February 28, 2017
November 7, 2017
November 2016
October 23, 2017   (Final data collection date for primary outcome measure)
Change in facial Sebum production at 4 weeks [ Time Frame: 4 weeks ]
The investigators will use Sebutapes placed on the forehead to measure facial sebum production for 60 minutes at baseline and after 4 weeks. The tapes will collect the facial sebum produced during that time.
Same as current
Complete list of historical versions of study NCT03065504 on Archive Site
Change from baseline in sebum profile, such as inflammatory markers, at 4 weeks [ Time Frame: 4 weeks ]
Same as current
Not Provided
Not Provided
Turmeric and Turmeric-containing Tablets and Sebum Production
Pilot Study on the Effects of Oral Turmeric and Turmeric-containing Tablets on Sebum Production
A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.

Turmeric (Curcuma longa) is a spice that has been shown to exhibit anti-inflammatory, antimicrobial, antioxidant, anti-neoplastic properties, and even potential to improve mental illnesses. In western herbalism, Turmeric is primarily used as an anti-inflammatory agent. In India, turmeric is used in Ayurevdic medicine for the treatment of acne. It has been used both internally and externally.

Curcumin is a phytochemical derived from turmeric and believed to be one of the key active components of turmeric. Curcumin is reported to have activity as an antibacterial and anti-inflammatory agent and has been used as a paste for skin eruptions and infections. Previous basic science work by Dr. Raja Sivamani's lab has shown that both turmeric and curcumin inhibit lipid synthesis in human sebocytes, the cells responsible for the production of sebum

The goal of this study is to evaluate how ingestion of turmeric and tablets that have a combination of herbs including turmeric may modulate sebum production.

Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Skin Inflammation
  • Dietary Supplement: Turmeric
  • Dietary Supplement: Turmeric-containing combination tablet
  • Dietary Supplement: Placebo tablets
  • Active Comparator: Turmeric group

    2,000 mg turmeric per day - supplied by Banyan® Botanicals )

    o Each tablet contains 500 mg of Turmeric (Curcuma longa). Subjects will take 2 tablets twice per day, with a total daily dose of 2,000 mg.

    Intervention: Dietary Supplement: Turmeric
  • Active Comparator: Turmeric-containing combination tablets

    • 2,000 mg Healthy Skin™ Tablets, contains:

    • Turmeric (Curcuma longa) - 50 mg/tablet
    • Hemidesmus Indicus root (Anantamul)
    • Indian Madder root
    • Neem leaf
    • Gotu Kola leaf
    • Indian TInospora stem
    • Amla fruit
    • Licorice root
    • Phyllanthus Amarus herb Each tablet contains 500mg total of the above herbs. There is 50 mg of Turmeric in each Healthy Skin ™ tablet. Subjects will take 2 tablets twice per day, which will be a total daily dose of 200 mg of Turmeric. This is comparable to the daily amount of Turmeric in many commercially-available Turmeric supplements; therefore, it is valuable to compare this formulation to the turmeric-only tablets.
    Intervention: Dietary Supplement: Turmeric-containing combination tablet
  • Placebo Comparator: Placebo tablets group
    • Supplement appearing similar to those in the turmeric and curcumin groups, supplied by Banyan® Botanicals
    • Ingredients (all organic): Placebo ingredients: Rice hulls concentrate, Maltodextrin, Micro Crystalline Cellulose, Beet Root Powder, Dutch coco powder
    • Dose: subjects in this group will take 2 tablets twice per day
    Intervention: Dietary Supplement: Placebo tablets

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Active, not recruiting
September 4, 2018
October 23, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Age 18 to 50 years of age, and
  2. Subject must be able to read and comprehend study procedures and consent forms.

Exclusion Criteria:

  1. Subject should be generally healthy and have no smoking history in the past one year, and must have no history of diabetes, metabolic syndrome, known cardiovascular disease, malignancy, kidney disease, or chronic steroid use.
  2. Subjects who consume more than 6 servings of caffeine per day, such as coffee and energy drinks (example - Red Bull).
  3. Subjects with known allergies to herbal ingredients.
  4. Subjects with known EKG changes.
  5. Those who used topical medications in the past two weeks or systemic antibiotics within one month of starting the study.
  6. Subjects who are postmenopausal
  7. Those who are pregnant or breastfeeding.
  8. Those that are prisoners or cognitively impaired.
Sexes Eligible for Study: All
18 Years to 60 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Plan to Share IPD: No
University of California, Davis
University of California, Davis
Not Provided
Principal Investigator: Raja K Sivamani, M.D. University of California, Davis
University of California, Davis
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP